164 related articles for article (PubMed ID: 35920016)
21. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of primary vitreoretinal lymphoma developing extra-central nervous system (CNS)/testicular lymphomas with or without CNS involvement: A single-centre study of 13 cases.
Kunimi K; Usui Y; Sugawara R; Asakage M; Tsubota K; Gotoh A; Goto H
Br J Haematol; 2023 Apr; 201(1):158-161. PubMed ID: 36693806
[No Abstract] [Full Text] [Related]
24. Recurrence of Intraretinal Infiltration of Vitreoretinal Lymphoma.
Gu J; Zhang K; Chang Q
Ophthalmol Retina; 2023 Nov; 7(11):998. PubMed ID: 37462594
[No Abstract] [Full Text] [Related]
25. [Isolated primary vitreoretinal lymphoma (case report)].
Stoyukhina AS; Korobov EN; Smolin SA
Vestn Oftalmol; 2024; 140(2. Vyp. 2):94-101. PubMed ID: 38739137
[TBL] [Abstract][Full Text] [Related]
26. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I; Sander P; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Steinhilber J; Kohler E; Büssgen M; Schittenhelm J; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Blood Adv; 2022 Mar; 6(5):1598-1607. PubMed ID: 34448823
[TBL] [Abstract][Full Text] [Related]
27. Intraocular lymphoma: more questions than answers.
Wakefield D; Zierhut M
Ocul Immunol Inflamm; 2009; 17(1):6-10. PubMed ID: 19294566
[No Abstract] [Full Text] [Related]
28. Mighty MyD88 in Health and Disease.
Pulido JS; Raja H; Vile RG; Salomao DR; Viswanatha DS
Retina; 2016 Mar; 36(3):429-31. PubMed ID: 26655610
[No Abstract] [Full Text] [Related]
29. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
30. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
31. Vitreoretinal Lymphoma: Optimizing Diagnostic Yield and Accuracy.
Santos MC; Jiang A; Li AS; Rao PK; Wilson B; Harocopos GJ
Am J Ophthalmol; 2022 Apr; 236():120-129. PubMed ID: 34626574
[TBL] [Abstract][Full Text] [Related]
32. Vitreoretinal lymphoma versus uveitis: cytokine profile and correlations.
Caraballo JN; Snyder MR; Johnston PB; O Neill BP; Raja H; Balsanek JG; Peters BE; Pulido JS
Ocul Immunol Inflamm; 2014 Feb; 22(1):34-41. PubMed ID: 24490677
[TBL] [Abstract][Full Text] [Related]
33. Steroid-induced delayed diagnosis of primary vitreoretinal lymphoma with ghost brain tumor: A case report.
Kau HC; Wang CJ; Tsai CC
Medicine (Baltimore); 2022 Jul; 101(29):e29637. PubMed ID: 35866822
[TBL] [Abstract][Full Text] [Related]
34. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
[TBL] [Abstract][Full Text] [Related]
35. Serial Detection of
Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
[TBL] [Abstract][Full Text] [Related]
36. [Ⅳ. Advances in Diagnosis and Treatment of Vitreoretinal Lymphoma].
Taoka K
Gan To Kagaku Ryoho; 2023 May; 50(5):605-610. PubMed ID: 37218321
[No Abstract] [Full Text] [Related]
37. Diagnosis of intraocular lymphoma.
Davis JL
Ocul Immunol Inflamm; 2004 Mar; 12(1):7-16. PubMed ID: 15209459
[TBL] [Abstract][Full Text] [Related]
38. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
Kvopka M; Lake SR; Smith JR
Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
[TBL] [Abstract][Full Text] [Related]
39. Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.
Baron M; Belin L; Cassoux N; Fardeau C; Blaizeau M; Soussain C; Houillier C; Hoang-Xuan K; Gyan E; Le Lez ML; Lavaud A; Soubeyran P; Bodaghi B; Costopoulos M; Leblond V; Touitou V; Maloum K; Errera MH; Roos-Weil D; Le Garff-Tavernier M; Choquet S
Blood; 2020 May; 135(20):1811-1815. PubMed ID: 32125361
[No Abstract] [Full Text] [Related]
40. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
